<DOC>
	<DOC>NCT01117220</DOC>
	<brief_summary>The purpose of this study is to determine if flexibly-dosed ziprasidone is safe and effective for the treatment of children and adolescents (ages 10-17) with Bipolar l Disorder (Manic or Mixed).</brief_summary>
	<brief_title>Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria for Bipolar I disorder (manic or mixed) At the screening and baseline visits, subjects must have a Young Mania Rating Scale (YMRS) score of at least 17. The subject must have a Body Mass Index (BMI) z score between 1.65 and +2.00, inclusive Imminent risk of suicide or homicide, as judged by the site investigator Any history of serious or unstable illness Risk for prolonged QT</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>pediatric</keyword>
	<keyword>bipolar</keyword>
</DOC>